We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TLRY market cap is 1.33B. The company's latest EPS is USD -1.9558 and P/E is -0.91.
Quarter End | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 144.14M | 147.56M | 182.72M | 188.06M | 193.47M |
Operating Income | -42.94M | -93.57M | -1.21B | -34.36M | -41.78M |
Net Income | -69.46M | -1.17B | -138.71M | -71.53M | -49.01M |
Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 198.41M | 210.48M | 513.09M | 673.02M | 627.63M |
Operating Income | -296.32M | -186.97M | -132.63M | -611.08M | -1.37B |
Net Income | -321.17M | -271.07M | -367.42M | -476.8M | -1.45B |
Quarter End | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.47B | 4.38B | 4.31B | 4.4B | 4.33B |
Total Liabilities | 991.23M | 969.13M | 977.32M | 1B | 937.2M |
Total Equity | 4.48B | 3.41B | 3.33B | 3.4B | 3.39B |
Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 896.33M | 945.95M | 6.03B | 5.45B | 4.31B |
Total Liabilities | 611.06M | 572.05M | 1.56B | 1.01B | 977.32M |
Total Equity | 285.27M | 373.9M | 4.47B | 4.44B | 3.33B |
Quarter End | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -17.06M | -35.69M | 7.91M | -15.84M | -46.25M |
Investing | -272.94M | -277.53M | -285.11M | -26.29M | 55.21M |
Financing | 66.36M | 63.92M | 70.16M | 14.02M | -71.35M |
Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -258.07M | -129.35M | -44.72M | -177.26M | 7.91M |
Investing | -253.18M | -41.68M | 46.11M | -21.53M | -285.11M |
Financing | 114.7M | 264.85M | 124.31M | 128.2M | 70.16M |
Market Cap | 1.33B |
Price to Earnings Ratio | -0.91 |
Price to Sales Ratio | 2.09 |
Price to Cash Ratio | 6.36 |
Price to Book Ratio | 0.39 |
Dividend Yield | - |
Shares Outstanding | 742.73M |
Average Volume (1 week) | 19.72M |
Average Volume (1 Month) | 37.72M |
52 Week Change | -23.50% |
52 Week High | 3.40 |
52 Week Low | 1.50 |
Spread (Intraday) | 0.01 (0.56%) |
Company Name | Tilray Brands Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.tilray.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions